PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Levobunolol hydrochloride - Glaucoma / ocular hypertension
PAD Profile : Levobunolol hydrochloride - Glaucoma / ocular hypertension Important
Keywords :
Intra-ocular pressure
Brand Names Include :
Betagan
Important Information :
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care.
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Latanoprost
- Bimatoprost
- Timolol
- Dorzolamide and timolol
- Brinzolamide
- Brimonidine tartrate
- Dorzolamide
- Latanoprost and timolol
- Acetazolamide
- Timolol and bimatoprost
- Timolol and brimonidine
- Brinzolamide/brimonidine
- Brinzolamide and timolol
- Tafluprost
- Travoprost
- Timolol and travoprost
- Pilocarpine hydrochloride
- Betaxolol
- Apraclonidine
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
02 October 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
11. Eye
11.06.00. Treatment of glaucoma